Cargando…
Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series
OBJECTIVE: Rituximab is a CD20-directed cytolytic antibody used for non-Hodgkin lymphoma, chronic lymphocytic leukaemia and RA, and off label for JIA, multiple sclerosis and lupus. Owing to concerns about infant B cell depletion, the manufacturer recommends avoidance of rituximab throughout pregnanc...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819866/ https://www.ncbi.nlm.nih.gov/pubmed/33521513 http://dx.doi.org/10.1093/rap/rkaa074 |